312 related articles for article (PubMed ID: 26473840)
1. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
[TBL] [Abstract][Full Text] [Related]
2. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
3. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
Thomas N; Bechet D; Becuwe P; Tirand L; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
J Photochem Photobiol B; 2009 Aug; 96(2):101-8. PubMed ID: 19464192
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.
Thomas N; Tirand L; Chatelut E; Plénat F; Frochot C; Dodeller M; Guillemin F; Barberi-Heyob M
Photochem Photobiol Sci; 2008 Apr; 7(4):433-41. PubMed ID: 18385885
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.
Thomas N; Pernot M; Vanderesse R; Becuwe P; Kamarulzaman E; Da Silva D; François A; Frochot C; Guillemin F; Barberi-Heyob M
Biochem Pharmacol; 2010 Jul; 80(2):226-35. PubMed ID: 20380812
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.
Tirand L; Thomas N; Dodeller M; Dumas D; Frochot C; Maunit B; Guillemin F; Barberi-Heyob M
Drug Metab Dispos; 2007 May; 35(5):806-13. PubMed ID: 17283031
[TBL] [Abstract][Full Text] [Related]
7. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
[TBL] [Abstract][Full Text] [Related]
8. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
Yan YJ; Zheng MZ; Chen ZL; Yu XH; Yang XX; Ding ZL; Xu L
Bioorg Med Chem; 2010 Sep; 18(17):6282-91. PubMed ID: 20691601
[TBL] [Abstract][Full Text] [Related]
9. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma.
Li PX; Mu JH; Xiao HL; Li DH
Oncol Rep; 2015 Jan; 33(1):125-32. PubMed ID: 25376180
[TBL] [Abstract][Full Text] [Related]
11. Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer.
Hamblin MR; Miller JL; Rizvi I; Ortel B; Maytin EV; Hasan T
Cancer Res; 2001 Oct; 61(19):7155-62. PubMed ID: 11585749
[TBL] [Abstract][Full Text] [Related]
12. Comparison between porphin, chlorin and bacteriochlorin derivatives for photodynamic therapy: Synthesis, photophysical properties, and biological activity.
Zhu W; Gao YH; Liao PY; Chen DY; Sun NN; Nguyen Thi PA; Yan YJ; Wu XF; Chen ZL
Eur J Med Chem; 2018 Dec; 160():146-156. PubMed ID: 30336449
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy.
Asano R; Nagami A; Fukumoto Y; Yazama F; Ito H; Sakata I; Tai A
Bioorg Med Chem; 2013 Apr; 21(8):2298-2304. PubMed ID: 23477944
[TBL] [Abstract][Full Text] [Related]
14. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel 3
Zhang XJ; Han GY; Guo CY; Ma ZQ; Lin MY; Wang Y; Miao ZY; Zhang WN; Sheng CQ; Yao JZ
Eur J Med Chem; 2020 Dec; 207():112715. PubMed ID: 32846322
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.
Bechet D; Tirand L; Faivre B; Plénat F; Bonnet C; Bastogne T; Frochot C; Guillemin F; Barberi-Heyob M
Pharm Res; 2010 Mar; 27(3):468-79. PubMed ID: 20087632
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.
Thomas E; Colombeau L; Gries M; Peterlini T; Mathieu C; Thomas N; Boura C; Frochot C; Vanderesse R; Lux F; Barberi-Heyob M; Tillement O
Int J Nanomedicine; 2017; 12():7075-7088. PubMed ID: 29026302
[TBL] [Abstract][Full Text] [Related]
18. Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: Synthesis and photophysical properties.
Stallivieri A; Colombeau L; Jetpisbayeva G; Moussaron A; Myrzakhmetov B; Arnoux P; Acherar S; Vanderesse R; Frochot C
Bioorg Med Chem; 2017 Jan; 25(1):1-10. PubMed ID: 27769669
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, optical properties and preliminary in vitro photodynamic effect of pyridyl and quinoxalyl substituted chlorins.
Li J; Zhang X; Liu Y; Yoon I; Kim DK; Yin JG; Wang JJ; Shim YK
Bioorg Med Chem; 2015 Apr; 23(8):1684-90. PubMed ID: 25797162
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.
Li XY; Yan N; Wu YY; Kong RJ; Qiu ZW; Liu SP; Wu DH; Cheng H
ACS Appl Mater Interfaces; 2024 May; 16(17):21709-21721. PubMed ID: 38651381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
